Integrative Health Technologies Inc
Integrative Health Technologies, Inc. provides fee-based clinical trials, research and development, and consulting and testing services to the healthcare and nutritional industries. The company maintains a database that contains more than 30,000 tests and dates back more than 20 years which tracks the footprints of diseases. It also operates mobile and stationary dual energy x-ray absorptiometry … Read more
Integrative Health Technologies Inc (IHTI) - Net Assets
Latest net assets as of September 2007: $8.68 Million USD
Based on the latest financial reports, Integrative Health Technologies Inc (IHTI) has net assets worth $8.68 Million USD as of September 2007.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.91 Million) and total liabilities ($225.17K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $8.68 Million |
| % of Total Assets | 97.47% |
| Annual Growth Rate | N/A |
| 5-Year Change | 1985.2% |
| 10-Year Change | N/A |
| Growth Volatility | 1005.28 |
Integrative Health Technologies Inc - Net Assets Trend (2002–2009)
This chart illustrates how Integrative Health Technologies Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Integrative Health Technologies Inc (2002–2009)
The table below shows the annual net assets of Integrative Health Technologies Inc from 2002 to 2009.
| Year | Net Assets | Change |
|---|---|---|
| 2009-12-31 | $7.95 Million | +6.78% |
| 2008-12-31 | $7.45 Million | +8.02% |
| 2007-12-31 | $6.90 Million | -25.23% |
| 2006-12-31 | $9.22 Million | +2317.92% |
| 2005-12-31 | $381.45K | +935.96% |
| 2004-12-31 | $-45.63K | +89.77% |
| 2003-12-31 | $-445.90K | -1374.78% |
| 2002-12-31 | $-30.23K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Integrative Health Technologies Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 233930300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2009)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $40.64K | 0.51% |
| Other Components | $10.41 Million | 130.93% |
| Total Equity | $7.95 Million | 100.00% |
Integrative Health Technologies Inc Competitors by Market Cap
The table below lists competitors of Integrative Health Technologies Inc ranked by their market capitalization.
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Integrative Health Technologies Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2008 to 2009, total equity changed from 7,449,179 to 7,953,966, a change of 504,787 (6.8%).
- Net income of 38,689 contributed positively to equity growth.
- Other factors increased equity by 466,098.
Equity Change Factors (2008 to 2009)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $38.69K | +0.49% |
| Other Changes | $466.10K | +5.86% |
| Total Change | $- | 6.78% |
Book Value vs Market Value Analysis
This analysis compares Integrative Health Technologies Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | $-0.42 | $0.00 | x |
| 2003-12-31 | $-6.30 | $0.00 | x |
| 2004-12-31 | $-0.09 | $0.00 | x |
| 2005-12-31 | $0.51 | $0.00 | x |
| 2006-12-31 | $12.74 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Integrative Health Technologies Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.49%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.65%
- • Asset Turnover: 0.05x
- • Equity Multiplier: 1.04x
- Recent ROE (0.49%) is above the historical average (-1.71%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 0.00% | 0.00% | 0.00x | 0.00x | $-14.99K |
| 2003 | 0.00% | 0.00% | 0.00x | 0.00x | $-603.41K |
| 2004 | 0.00% | 0.00% | 0.00x | 0.00x | $-2.53 Million |
| 2005 | -14.46% | 0.00% | 0.00x | 3.51x | $-93.32K |
| 2006 | -0.40% | -250.05% | 0.00x | 1.05x | $-959.50K |
| 2007 | 0.31% | 3.76% | 0.08x | 1.04x | $-668.34K |
| 2008 | 0.36% | 6.14% | 0.06x | 1.04x | $-718.43K |
| 2009 | 0.49% | 8.65% | 0.05x | 1.04x | $-756.71K |
Industry Comparison
This section compares Integrative Health Technologies Inc's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $914,015,556
- Average return on equity (ROE) among peers: -22.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Integrative Health Technologies Inc (IHTI) | $8.68 Million | 0.00% | 0.03x | $7.69 |
| Agilent Technologies Inc (A) | $4.08 Billion | 3.46% | 0.65x | $31.80 Billion |
| Amer Bio Medica (ABMC) | $3.38 Million | -26.64% | 1.08x | $3.55K |
| ADCNF (ADCNF) | $1.77 Billion | 2.65% | 1.64x | $172.01 Million |
| Advanced Biomed Inc. Common Stock (ADVB) | $3.48 Billion | 0.00% | 0.87x | $1.68 Million |
| ANGLE plc (ANPCF) | $18.44 Million | -77.14% | 0.38x | $34.42 Million |
| SeqLL Inc. (ATLN) | $8.18 Million | -45.26% | 0.31x | $35.63K |
| Avricore Health Inc (AVCRF) | $2.20 Million | -79.50% | 0.04x | $3.22 Million |
| Aspira Womens Health Inc (AWH) | $-11.46 Million | 0.00% | 0.00x | $664.47K |
| Biodesix Inc (BDSX) | $-198.03 Million | 0.00% | 0.00x | $50.38 Million |
| bioAffinity Technologies, Inc. (BIAF) | $-15.79 Million | 0.00% | 0.00x | $5.08 Million |